Your browser doesn't support javascript.
loading
Lenvatinib plus Pembrolizumab Combination Therapy for Advanced or Recurrent Endometrial Cancer: A Single-Center, Retrospective Analysis.
Tochigi, Mikako; Shigeta, Shogo; Shimada, Muneaki; Miyahara, Shuko; Hasegawa-Minato, Junko; Shibuya, Yusuke; Ishibashi, Masumi; Hashimoto, Chiaki; Tokunaga, Hideki; Yaegashi, Nobuo.
Afiliação
  • Tochigi M; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
  • Shigeta S; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
  • Shimada M; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
  • Miyahara S; Tohoku University Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University.
  • Hasegawa-Minato J; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
  • Shibuya Y; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
  • Ishibashi M; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
  • Hashimoto C; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
  • Tokunaga H; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
  • Yaegashi N; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Tohoku J Exp Med ; 262(2): 85-95, 2024 Feb 27.
Article em En | MEDLINE | ID: mdl-38008437

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio / Anticorpos Monoclonais Humanizados Limite: Female / Humans Idioma: En Revista: Tohoku J Exp Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Endométrio / Anticorpos Monoclonais Humanizados Limite: Female / Humans Idioma: En Revista: Tohoku J Exp Med Ano de publicação: 2024 Tipo de documento: Article